Hartland & Co »

Ascendis Pharma A S shares owned by Hartland & Co

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Hartland & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $115k 915 125.95
2023-09-30 $79k 845 93.64
2023-06-30 $104k 1.2k 89.25
2023-03-31 $67k 620 107.22

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Small Cp Etf (VB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr S&p Divid Etf (SDY)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Russell 3000 Etf (IWV)

View all positions for Hartland & Co

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
Massachusetts Financial Services
T. Rowe Price Associates
Franklin Resources
TimesSquare Capital Management
Brown Advisory Holdings Incorporated
Alliancebernstein
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Paradigm Biocapital Advisors

View all funds holding Ascendis Pharma A S